Global Hepatitis C Treatment Market Professional Survey Report 2017

December 2017 | 108 pages | ID: G64882A36CDEN
QYResearch

Abstracts

This report studies Hepatitis C Treatment in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• AbbieVie Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• Gilead Sciences Inc.
• GlaxoSmith Kline Plc.
• Janssen Pharmaceuticals Inc.
• Merck & Co. Inc.
• Schering AG
• Vertex Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• HCV Protease Inhibitors
• HCV Polymerase Inhibitors
• HCV NS5A Inhibitors
• Combination Therapy
• Interferon and Antiviral
• Others

By Application, the market can be split into

• Hospital
• Clinic
• Home Care

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Hepatitis C Treatment Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF HEPATITIS C TREATMENT

1.1 Definition and Specifications of Hepatitis C Treatment
  1.1.1 Definition of Hepatitis C Treatment
  1.1.2 Specifications of Hepatitis C Treatment
1.2 Classification of Hepatitis C Treatment
  1.2.1 HCV Protease Inhibitors
  1.2.2 HCV Polymerase Inhibitors
  1.2.3 HCV NS5A Inhibitors
  1.2.4 Combination Therapy
  1.2.5 Interferon and Antiviral
  1.2.6 Others
1.3 Applications of Hepatitis C Treatment
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Home Care
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF HEPATITIS C TREATMENT

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hepatitis C Treatment
2.3 Manufacturing Process Analysis of Hepatitis C Treatment
2.4 Industry Chain Structure of Hepatitis C Treatment

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF HEPATITIS C TREATMENT

3.1 Capacity and Commercial Production Date of Global Hepatitis C Treatment Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Hepatitis C Treatment Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Hepatitis C Treatment Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Hepatitis C Treatment Major Manufacturers in 2016

4 GLOBAL HEPATITIS C TREATMENT OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Hepatitis C Treatment Capacity and Growth Rate Analysis
  4.2.2 2016 Hepatitis C Treatment Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Hepatitis C Treatment Sales and Growth Rate Analysis
  4.3.2 2016 Hepatitis C Treatment Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Hepatitis C Treatment Sales Price
  4.4.2 2016 Hepatitis C Treatment Sales Price Analysis (Company Segment)

5 HEPATITIS C TREATMENT REGIONAL MARKET ANALYSIS

5.1 North America Hepatitis C Treatment Market Analysis
  5.1.1 North America Hepatitis C Treatment Market Overview
  5.1.2 North America 2012-2017E Hepatitis C Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Hepatitis C Treatment Sales Price Analysis
  5.1.4 North America 2016 Hepatitis C Treatment Market Share Analysis
5.2 China Hepatitis C Treatment Market Analysis
  5.2.1 China Hepatitis C Treatment Market Overview
  5.2.2 China 2012-2017E Hepatitis C Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Hepatitis C Treatment Sales Price Analysis
  5.2.4 China 2016 Hepatitis C Treatment Market Share Analysis
5.3 Europe Hepatitis C Treatment Market Analysis
  5.3.1 Europe Hepatitis C Treatment Market Overview
  5.3.2 Europe 2012-2017E Hepatitis C Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Hepatitis C Treatment Sales Price Analysis
  5.3.4 Europe 2016 Hepatitis C Treatment Market Share Analysis
5.4 Southeast Asia Hepatitis C Treatment Market Analysis
  5.4.1 Southeast Asia Hepatitis C Treatment Market Overview
  5.4.2 Southeast Asia 2012-2017E Hepatitis C Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Hepatitis C Treatment Sales Price Analysis
  5.4.4 Southeast Asia 2016 Hepatitis C Treatment Market Share Analysis
5.5 Japan Hepatitis C Treatment Market Analysis
  5.5.1 Japan Hepatitis C Treatment Market Overview
  5.5.2 Japan 2012-2017E Hepatitis C Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Hepatitis C Treatment Sales Price Analysis
  5.5.4 Japan 2016 Hepatitis C Treatment Market Share Analysis
5.6 India Hepatitis C Treatment Market Analysis
  5.6.1 India Hepatitis C Treatment Market Overview
  5.6.2 India 2012-2017E Hepatitis C Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Hepatitis C Treatment Sales Price Analysis
  5.6.4 India 2016 Hepatitis C Treatment Market Share Analysis

6 GLOBAL 2012-2017E HEPATITIS C TREATMENT SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Hepatitis C Treatment Sales by Type
6.2 Different Types of Hepatitis C Treatment Product Interview Price Analysis
6.3 Different Types of Hepatitis C Treatment Product Driving Factors Analysis
  6.3.1 HCV Protease Inhibitors of Hepatitis C Treatment Growth Driving Factor Analysis
  6.3.2 HCV Polymerase Inhibitors of Hepatitis C Treatment Growth Driving Factor Analysis
  6.3.3 HCV NS5A Inhibitors of Hepatitis C Treatment Growth Driving Factor Analysis
  6.3.4 Combination Therapy of Hepatitis C Treatment Growth Driving Factor Analysis
  6.3.5 Interferon and Antiviral of Hepatitis C Treatment Growth Driving Factor Analysis
  6.3.6 Others of Hepatitis C Treatment Growth Driving Factor Analysis

7 GLOBAL 2012-2017E HEPATITIS C TREATMENT SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Hepatitis C Treatment Consumption by Application
7.2 Different Application of Hepatitis C Treatment Product Interview Price Analysis
7.3 Different Application of Hepatitis C Treatment Product Driving Factors Analysis
  7.3.1 Hospital of Hepatitis C Treatment Growth Driving Factor Analysis
  7.3.2 Clinic of Hepatitis C Treatment Growth Driving Factor Analysis
  7.3.3 Home Care of Hepatitis C Treatment Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF HEPATITIS C TREATMENT

8.1 AbbieVie Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AbbieVie Inc. 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AbbieVie Inc. 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.2 Bristol-Myers Squibb Company
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Bristol-Myers Squibb Company 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bristol-Myers Squibb Company 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.3 F. Hoffmann-La Roche AG
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 F. Hoffmann-La Roche AG 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 F. Hoffmann-La Roche AG 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.4 Gilead Sciences Inc.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Gilead Sciences Inc. 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Gilead Sciences Inc. 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.5 GlaxoSmith Kline Plc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 GlaxoSmith Kline Plc. 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 GlaxoSmith Kline Plc. 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.6 Janssen Pharmaceuticals Inc.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Janssen Pharmaceuticals Inc. 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Janssen Pharmaceuticals Inc. 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.7 Merck & Co. Inc.
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Merck & Co. Inc. 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Merck & Co. Inc. 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.8 Schering AG
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Schering AG 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Schering AG 2016 Hepatitis C Treatment Business Region Distribution Analysis
8.9 Vertex Pharmaceuticals
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Vertex Pharmaceuticals 2016 Hepatitis C Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Vertex Pharmaceuticals 2016 Hepatitis C Treatment Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF HEPATITIS C TREATMENT MARKET

9.1 Global Hepatitis C Treatment Market Trend Analysis
  9.1.1 Global 2017-2022 Hepatitis C Treatment Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Hepatitis C Treatment Sales Price Forecast
9.2 Hepatitis C Treatment Regional Market Trend
  9.2.1 North America 2017-2022 Hepatitis C Treatment Consumption Forecast
  9.2.2 China 2017-2022 Hepatitis C Treatment Consumption Forecast
  9.2.3 Europe 2017-2022 Hepatitis C Treatment Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Hepatitis C Treatment Consumption Forecast
  9.2.5 Japan 2017-2022 Hepatitis C Treatment Consumption Forecast
  9.2.6 India 2017-2022 Hepatitis C Treatment Consumption Forecast
9.3 Hepatitis C Treatment Market Trend (Product Type)
9.4 Hepatitis C Treatment Market Trend (Application)

10 HEPATITIS C TREATMENT MARKETING TYPE ANALYSIS

10.1 Hepatitis C Treatment Regional Marketing Type Analysis
10.2 Hepatitis C Treatment International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hepatitis C Treatment by Region
10.4 Hepatitis C Treatment Supply Chain Analysis

11 CONSUMERS ANALYSIS OF HEPATITIS C TREATMENT

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL HEPATITIS C TREATMENT MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hepatitis C Treatment
Table Product Specifications of Hepatitis C Treatment
Table Classification of Hepatitis C Treatment
Figure Global Production Market Share of Hepatitis C Treatment by Type in 2016
Figure HCV Protease Inhibitors Picture
Table Major Manufacturers of HCV Protease Inhibitors
Figure HCV Polymerase Inhibitors Picture
Table Major Manufacturers of HCV Polymerase Inhibitors
Figure HCV NS5A Inhibitors Picture
Table Major Manufacturers of HCV NS5A Inhibitors
Figure Combination Therapy Picture
Table Major Manufacturers of Combination Therapy
Figure Interferon and Antiviral Picture
Table Major Manufacturers of Interferon and Antiviral
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Hepatitis C Treatment
Figure Global Consumption Volume Market Share of Hepatitis C Treatment by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Home Care Examples
Table Major Consumers in Home Care
Figure Market Share of Hepatitis C Treatment by Regions
Figure North America Hepatitis C Treatment Market Size (Million USD) (2012-2022)
Figure China Hepatitis C Treatment Market Size (Million USD) (2012-2022)
Figure Europe Hepatitis C Treatment Market Size (Million USD) (2012-2022)
Figure Southeast Asia Hepatitis C Treatment Market Size (Million USD) (2012-2022)
Figure Japan Hepatitis C Treatment Market Size (Million USD) (2012-2022)
Figure India Hepatitis C Treatment Market Size (Million USD) (2012-2022)
Table Hepatitis C Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hepatitis C Treatment in 2016
Figure Manufacturing Process Analysis of Hepatitis C Treatment
Figure Industry Chain Structure of Hepatitis C Treatment
Table Capacity and Commercial Production Date of Global Hepatitis C Treatment Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Hepatitis C Treatment Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Hepatitis C Treatment Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Hepatitis C Treatment Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Hepatitis C Treatment 2012-2017
Figure Global 2012-2017E Hepatitis C Treatment Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Hepatitis C Treatment Market Size (Value) and Growth Rate
Table 2012-2017E Global Hepatitis C Treatment Capacity and Growth Rate
Table 2016 Global Hepatitis C Treatment Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Hepatitis C Treatment Sales (K Pcs) and Growth Rate
Table 2016 Global Hepatitis C Treatment Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Hepatitis C Treatment Sales Price (USD/Pcs)
Table 2016 Global Hepatitis C Treatment Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Hepatitis C Treatment 2012-2017E
Figure North America 2012-2017E Hepatitis C Treatment Sales Price (USD/Pcs)
Figure North America 2016 Hepatitis C Treatment Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Hepatitis C Treatment 2012-2017E
Figure China 2012-2017E Hepatitis C Treatment Sales Price (USD/Pcs)
Figure China 2016 Hepatitis C Treatment Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Hepatitis C Treatment 2012-2017E
Figure Europe 2012-2017E Hepatitis C Treatment Sales Price (USD/Pcs)
Figure Europe 2016 Hepatitis C Treatment Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Hepatitis C Treatment 2012-2017E
Figure Southeast Asia 2012-2017E Hepatitis C Treatment Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Hepatitis C Treatment Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Hepatitis C Treatment 2012-2017E
Figure Japan 2012-2017E Hepatitis C Treatment Sales Price (USD/Pcs)
Figure Japan 2016 Hepatitis C Treatment Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Hepatitis C Treatment 2012-2017E
Figure India 2012-2017E Hepatitis C Treatment Sales Price (USD/Pcs)
Figure India 2016 Hepatitis C Treatment Sales Market Share
Table Global 2012-2017E Hepatitis C Treatment Sales (K Pcs) by Type
Table Different Types Hepatitis C Treatment Product Interview Price
Table Global 2012-2017E Hepatitis C Treatment Sales (K Pcs) by Application
Table Different Application Hepatitis C Treatment Product Interview Price
Table AbbieVie Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 AbbieVie Inc. Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AbbieVie Inc. Hepatitis C Treatment Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Company Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bristol-Myers Squibb Company Hepatitis C Treatment Business Region Distribution
Table F. Hoffmann-La Roche AG Information List
Table Product A Overview
Table Product B Overview
Table 2015 F. Hoffmann-La Roche AG Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 F. Hoffmann-La Roche AG Hepatitis C Treatment Business Region Distribution
Table Gilead Sciences Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gilead Sciences Inc. Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Gilead Sciences Inc. Hepatitis C Treatment Business Region Distribution
Table GlaxoSmith Kline Plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmith Kline Plc. Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmith Kline Plc. Hepatitis C Treatment Business Region Distribution
Table Janssen Pharmaceuticals Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Janssen Pharmaceuticals Inc. Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Janssen Pharmaceuticals Inc. Hepatitis C Treatment Business Region Distribution
Table Merck & Co. Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co. Inc. Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck & Co. Inc. Hepatitis C Treatment Business Region Distribution
Table Schering AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Schering AG Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Schering AG Hepatitis C Treatment Business Region Distribution
Table Vertex Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Vertex Pharmaceuticals Hepatitis C Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Vertex Pharmaceuticals Hepatitis C Treatment Business Region Distribution
Figure Global 2017-2022 Hepatitis C Treatment Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Hepatitis C Treatment Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Hepatitis C Treatment Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Hepatitis C Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Hepatitis C Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Hepatitis C Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Hepatitis C Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Hepatitis C Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Hepatitis C Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Hepatitis C Treatment by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Hepatitis C Treatment by Application 2017-2022
Table Traders or Distributors with Contact Information of Hepatitis C Treatment by Region